
Home > Newsroom > 2007 > Notice of Execution of Acquisition of the Company's Own Shares
Main contents starts here
June 26, 2007
OSAKA, Japan, June 26, 2007 --- Takeda Pharmaceutical Company Limited ("Takeda") announced today that it completed acquisition of its own shares in the market, which was resolved by its Board of Directors on May 18, 2007.
| 1. Class of shares acquired | : | Shares of common stock |
|---|---|---|
| 2. Period of acquisition | : | From May 21, 2007 to June 22, 2007 |
| 3. Total number of shared acquired | : | 3,631,100 shares |
| 4. Total value of acquisition | : | Yen 28,562,150,000 |
| 5. Method of acquisition | : | Purchased on the Tokyo Stock Exchange |
| 1. Class of shares to be acquired | : | Shares of common stock |
|---|---|---|
| 2. Number of shares to be acquired | : | Up to 10 million shares (equivalent to 1.12% of a total of issued shares) |
| 3. Total value of shares to be acquired | : | Up to 75 billion Yen |
| 4. Schedule of acquisition | : | From May 21, 2007 to June 22, 2007 |
# # #